US biotech Biogen has entered into a definitive agreement to acquire Massachusetts-based Alcyone Therapeutics, a company the ...

South Korean biotech CorestemChemon (Kosdaq: 166480) has shared Phase III ALSummit trial findings for its autologous stem ...

Portuguese venture firm Biovance Capital Partners has led a series A financing for Mondego Bio, joined by US investors ...

US drugmaker Eli Lilly’s battle for dominance of the GLP-1 weight loss and diabetes market with Novo Nordisk is becoming an epic.